[1] 韩鸿宾,谢静霞.MR扩散与灌注成像在脑缺血诊断中的诊断中的应用[J].中华放射学杂志,1998,32(6):364-368. [2] Le Bihan D, Breton E, Lallemand D, et al.Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging[J]. Radiology, 1988, 168(8):497. [3] 陈欣,闫锐,康华锋,等.不同扩散梯度因子值的乳腺MR扩散加权成像对比研究[J].中华放射学杂志,2009,43(4):356-359. [4] Yamada I, Aung W, Himeno Y, et al.Diffusion coefficients in abdominal organs and hepatic lesions:evaluation with intravoxel incoherent motion echo-planar MR imaging[J]. Radiology, 1999, 210(3):617-623. [5] 姚而固.WHO多发性骨髓瘤的诊断与分期[J].白血病·淋巴瘤,2004,13(2):116-117. [6] 徐文坚,徐爱德.骨髓弥漫性病变MRI应用和进展[J].中华放射学杂志,2001,35(6):423-424. [7] 魏来,管永靖,陈克敏.全身弥散成像对多发性骨髓瘤诊断价值初探[J].中国医学计算机成像杂志,2009,15(6):551-554 [8] Bauerle Tobias D, Hillengass Jens MD. et al. Multiple myeloma and monoclonal gammopathy of undetermined significance:importance of whole-body versus spinal MR imaging[J]. Radiology, 2009, 252(8):477-485. [9] 刘许慧,袁梅,秦斌,等.多发性骨髓瘤的临床及全身磁共振分析[J].医学影像学杂志,2011, 21(1):98-102. [10] 汤光宇,姚冀平,刘勇,等. 鉴别良、恶性椎体骨折的最佳扩散敏感系数值的探讨[J].中华放射学杂志,2004, 38(6):615-619. [11] Edgardo J C. MD, Athanasios B T, Fassas M D.et al.Multiple myeloma:clinical review and diagnostic imaging[J]. Radiology, 2004,231(4):11-23. [12] Judith S, Schreiman M D, Richrd A, et al. Multiple myeloma:evaluation by CT[J]. Radiology,1985, 252(2):483-486. [13] Bruno C, Vande Berg M D, Frederic E, et al. Stage I multiple myeloma:value of MR imaging of the bone marrow in the determination of prognosis[J]. Radiology, 1996, 201(10):243-246. [14] Corneliurs S, Mccarthy M D, Joshua A, et al. Multiple myeloma and contrast media[J]. Radiology, 1992, 183(15):519-521. [15] Chieh Lin, M D, Alain Luciani M D, PhD. et al. Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging:initial experience[J]. Radiology, 2009, 250(3):905-915. [16] 李涵,李倩,徐文贵,等. 18F-FDG PET/CT对初治多发性骨髓瘤患者预后判断价值分析[J].中华肿瘤防治杂志,2017,24(2):124-129. [17] 廖林波, 唐毓金,蓝常贡,等. 多发性骨髓瘤易感基因多态性的研究进展[J]. 临床肿瘤学杂志, 2018,23(3):279-283. |